SI
NVO

Sava Infond’s Novo Nordisk NVO Stock Holding History

Sava Infond’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$994K Hold
20,725
– – 0.07% 107
2026
Q1 		$762K Hold
20,725
– – 0.11% 114
2025
Q4 		$1.05M Sell
20,725
-2,000
-9% -$102K 0.14% 96
2025
Q3 		$1.26M Buy
22,725
+3,125
+16% +$183K 0.18% 84
2025
Q2 		$1.35M Sell
19,600
-1,100
-5% -$74.8K 0.21% 80
2025
Q1 		$1.44M Buy
20,700
+2,200
+12% +$182K 0.27% 78
2024
Q4 		$1.59M Buy
+18,500
New +$2M 0.28% 69

Other funds holding NVO

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Sava Infond's NVO Position: Q2 2026 in Review

Sava Infond held its Novo Nordisk (NVO) position steady in Q2 2026 at 20,725 shares worth $994K. The position accounts for 0.07% of the portfolio, ranked #107.

Sava Infond first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.59M in Q4 2024. 286 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Sava Infond held 20,725 shares of Novo Nordisk worth $994K as of Q2 2026.
  • Sava Infond left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.07% of Sava Infond's portfolio in Q2 2026, its #107 holding.
  • Sava Infond first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Sava Infond's Novo Nordisk position peaked at $1.59M in Q4 2024.
  • 286 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Sava Infond's 13F filing for Q2 2026, filed 16 Jul 2026.